As phosphorylation regulates the activity DNA-PKcs, we utilized immunohistochemistry to investigate the total and phosphorylated levels of DNA-PKcs (p–DNA-PKcs) in patients with melanoma undergoing ICB therapy and their response to treatment. The gene discussed is PRKDC; the disease is melanoma.